Asthma quality-of-care markers using administrative data.

STUDY OBJECTIVE To evaluate the relationship of potential asthma quality-of-care markers to subsequent emergency hospital care. DESIGN Retrospective administrative database analysis. SETTING Managed care organization. PATIENTS Asthmatic patients aged 5 to 56 years of age. INTERVENTIONS None. MEASUREMENTS AND RESULTS Candidate quality measures included one or more or four or more controller medication canisters, a controller/total asthma medication ratio of > or = 0.3 or > or = 0.5, and the dispensing of fewer than six beta-agonist canisters in 2002. Outcome was a 2003 asthma emergency department visit or hospitalization. Multivariable analyses adjusted for age, sex, and year 2002 severity (based on utilization). In the total sample (n = 109,774), one or more controllers (odds ratio, 1.35) and four or more controllers (odds ratio, 1.98) were associated with an increased risk of emergency hospital care, whereas a controller/total asthma medication ratio of > or = 0.5 (odds ratio, 0.73) and the dispensing of fewer than six beta-agonist canisters (odds ratio 0.30) were associated with a decreased risk. After adjustment for baseline severity in the total asthma sample, the controller/total asthma medication ratio (odds ratio, 0.62 to 0.78) and beta-agonist measure (odds ratio, 0.42) were associated with decreased risk, whereas the dispensing of four or more canisters of controller medication was associated with increased risk (odds ratio, 1.33). After stratification by year 2002 beta-agonist use, all of the measures were associated with decreased risk in those who received fewer than six beta-agonist canisters, whereas all of the measures except the medication ratio of > or = 0.5 were associated with increased risk in the cohort who received six or more beta-agonist canisters. CONCLUSION Controller use and beta-agonist use may function as severity indicators in large populations rather than as asthma quality-of-care markers. A medication ratio of > or = 0.5 appeared to function as the best quality-of-care marker in this study.

[1]  L. Boulet,et al.  Evaluation of asthma control by physicians and patients: comparison with current guidelines. , 2002, Canadian respiratory journal.

[2]  B. Bender,et al.  Assessing adherence with asthma medication: making the counts count. , 2002, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[3]  R. Pauwels,et al.  Low-dose inhaled corticosteroids and the prevention of death from asthma. , 2000, The New England journal of medicine.

[4]  R. Adams,et al.  Evaluation of Asthma Prescription Measures and Health System Performance Based on Emergency Department Utilization , 2004, Medical care.

[5]  B Järvholm,et al.  Asthma and asthma-like symptoms in adults assessed by questionnaires. A literature review. , 1993, Chest.

[6]  Paula Lozano,et al.  Inadequate use of asthma medication in the United States: results of the asthma in America national population survey. , 2002, The Journal of allergy and clinical immunology.

[7]  L. Hendeles,et al.  Telephoning the patient's pharmacy to assess adherence with asthma medications by measuring refill rate for prescriptions. , 2000, The Journal of pediatrics.

[8]  D. Mannino,et al.  Chronic obstructive pulmonary disease surveillance--United States, 1971-2000. , 2002, Morbidity and mortality weekly report. Surveillance summaries.

[9]  M. Zacharisen,et al.  National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma Update on Selected Topics--2002. , 2002, The Journal of allergy and clinical immunology.

[10]  G. O'Connor,et al.  Poverty, race, and medication use are correlates of asthma hospitalization rates. A small area analysis in Boston. , 1995, Chest.

[11]  P. Aveyard.  Assessing the performance of general practices caring for patients with asthma. , 1997, The British journal of general practice : the journal of the Royal College of General Practitioners.

[12]  S. Sullivan,et al.  The health economics of asthma and rhinitis. I. Assessing the economic impact. , 2001, The Journal of allergy and clinical immunology.

[13]  J. Donahue,et al.  Inhaled Steroids and the Risk of Hospitalization for Asthma , 1998 .

[14]  C. Pantin,et al.  Is the ratio of inhaled corticosteroid to bronchodilator a good indicator of the quality of asthma prescribing? Cross sectional study linking prescribing data to data on admissions , 1996, BMJ.

[15]  S. Weiss,et al.  The burden of asthma in the United States: level and distribution are dependent on interpretation of the national asthma education and prevention program guidelines. , 2002, American journal of respiratory and critical care medicine.

[16]  C. Griffiths,et al.  Prescribing and hospital admissions for asthma in east London , 1996, BMJ.

[17]  M. Blaiss,et al.  The utility of the Health Plan Employer Data and Information Set (HEDIS) asthma measure to predict asthma-related outcomes. , 2004, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[18]  Diana Petitti,et al.  Inhaled corticosteroids and allergy specialty care reduce emergency hospital use for asthma. , 2003, The Journal of allergy and clinical immunology.

[19]  D. Mannino,et al.  Surveillance for asthma--United States, 1980-1999. , 2002, Morbidity and mortality weekly report. Surveillance summaries.

[20]  D. Petitti,et al.  Asthma population management: development and validation of a practical 3-level risk stratification scheme. , 2004, The American journal of managed care.